Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Total Liabilities (2017 - 2026)

Updated

Takeda Pharmaceutical's Total Liabilities was $50.85 billion in the quarter ended Jun 30, 2026, up 3.1% from $49.33 billion a year earlier but down 1.3% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Total Liabilities (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Total Liabilities at Takeda Pharmaceutical came in at $53.68 billion, up 11.8% from the prior year.

  • Total Liabilities shows a five-year compound annual growth rate of -6.0% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Total Liabilities was $48 billion in the year ended Mar 31, 2025 (-11.6%), $54.33 billion in the year ended Mar 31, 2024 (-3.5%), $56.28 billion in the year ended Mar 31, 2023 (-15.7%) and $66.73 billion in the year ended Mar 31, 2022 (-8.5%).
  • Quarterly Total Liabilities has moved between $47.93 billion (the quarter ended Mar 31, 2025) and $64.47 billion (the quarter ended Mar 31, 2022) over five years.
  • Compared with a year earlier, Total Liabilities was higher in two of the last six quarters, with an average decline of 1.3%.
  • The best year-over-year quarter for Total Liabilities over five years was the quarter ended Mar 31, 2026 (growth of 7.5%); the worst was the quarter ended Mar 31, 2022 (a decline of 11.8%).
  • Per Business Quant data, TAK's Total Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $51.53 billion (quarter ended Mar 31, 2026), $50.45 billion (quarter ended Dec 31, 2025) and $49.81 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 50.85 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.85 Bn
Mar 31, 2026 51.53 Bn
Dec 31, 2025 50.45 Bn
Sep 30, 2025 49.81 Bn
Jun 30, 2025 49.33 Bn
Mar 31, 2025 47.93 Bn
Dec 31, 2024 50.57 Bn
Jun 30, 2024 54.14 Bn
Mar 31, 2024 52.87 Bn
Dec 31, 2023 50.61 Bn
Sep 30, 2023 54.02 Bn
Jun 30, 2023 57.43 Bn
Mar 31, 2023 57.48 Bn
Dec 31, 2022 51.87 Bn
Sep 30, 2022 57.02 Bn
Jun 30, 2022 59.91 Bn
Mar 31, 2022 64.47 Bn
Jun 30, 2021 67.21 Bn
Mar 31, 2021 73.08 Bn
Dec 31, 2020 73.18 Bn
API Access

Takeda Pharmaceutical Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEY